The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Regulatory News (VAL)

Share Price Information for ValiRx (VAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.25
Bid: 3.20
Ask: 3.30
Change: 0.00 (0.00%)
Spread: 0.10 (3.125%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.25
VAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

5 Jul 2022 11:45

RNS Number : 3864R
ValiRx PLC
05 July 2022
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

gb00blh13c52

Issuer Name

VALIRX PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

nicholas slater

City of registered office (if applicable)

mill hill

Country of registered office (if applicable)

United Kingdom

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

 

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached

04-Jul-2022

6. Date on which Issuer notified

04-Jul-2022

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

6.430000

0.000000

6.430000

5805945

Position of previous notification (if applicable)

2.340000

3.060000

5.400000

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

gb0000blh13c52

3996445

1809500

4.440000

1.990000

Sub Total 8.A

5805945

6.430000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

 

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

increased shareholding via placing

12. Date of Completion

04-Jul-2022

13. Place Of Completion

London

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLUVSRRUUUBRAR
Date   Source Headline
28th Sep 20214:41 pmRNSSecond Price Monitoring Extn
28th Sep 20214:36 pmRNSPrice Monitoring Extension
17th Sep 20214:41 pmRNSSecond Price Monitoring Extn
17th Sep 20214:36 pmRNSPrice Monitoring Extension
16th Sep 20217:00 amRNSNew Evaluation Agreement
8th Sep 20217:00 amRNSHolding(s) in Company
7th Sep 20217:00 amRNSHalf-year Report
25th Aug 20217:00 amRNSAppointment of Broker
20th Aug 20212:05 pmRNSSecond Price Monitoring Extn
20th Aug 20212:00 pmRNSPrice Monitoring Extension
6th Jul 20217:00 amRNSPatent update
17th Jun 20214:40 pmRNSSecond Price Monitoring Extn
17th Jun 20214:35 pmRNSPrice Monitoring Extension
27th May 202112:48 pmRNSResult of AGM
27th May 20217:00 amRNSKTH222 Evaluation Agreement Concluded
30th Apr 202112:00 pmRNSPosting of Annual Report and Notice of AGM
27th Apr 20217:00 amRNSFinal Results
1st Mar 20217:00 amRNSTotal Voting Rights
25th Feb 20217:00 amRNSBlock listing Interim Review
18th Feb 20213:39 pmRNSDirector/PDMR Shareholding
15th Feb 20217:00 amRNSExtension of Collaboration Agreement
19th Jan 202111:36 amRNSDirector Disclosure
19th Jan 20217:00 amRNSPatent Status Update
30th Nov 202011:04 amRNSHolding(s) in Company
30th Nov 20207:46 amRNSVAL201 Clinical Trial Full Data Results
10th Nov 20207:00 amRNSAgreement with Kalos Therapeutics
2nd Nov 20207:00 amRNSTotal Voting Rights and Block Listing Update
16th Oct 202011:05 amRNSSecond Price Monitoring Extn
16th Oct 202011:00 amRNSPrice Monitoring Extension
2nd Oct 20204:00 pmRNSExercise of Warrant
1st Oct 20207:00 amRNSTotal Voting Rights and Block Listing Update
30th Sep 202010:34 amRNSHolding(s) in Company
29th Sep 20204:13 pmRNSHolding(s) in Company
29th Sep 20207:00 amRNSExercise of Warrant
28th Sep 20204:41 pmRNSSecond Price Monitoring Extn
28th Sep 20204:35 pmRNSPrice Monitoring Extension
28th Sep 20207:00 amRNSVAL201 Clinical Trial Update
25th Sep 20204:41 pmRNSSecond Price Monitoring Extn
25th Sep 20204:36 pmRNSPrice Monitoring Extension
25th Sep 202011:55 amRNSHolding(s) in Company
24th Sep 202011:05 amRNSSecond Price Monitoring Extn
24th Sep 202011:00 amRNSPrice Monitoring Extension
23rd Sep 202012:39 pmRNSHolding(s) in Company
23rd Sep 20207:06 amRNSSecond Price Monitoring Extn
23rd Sep 20207:04 amRNSPrice Monitoring Extension
23rd Sep 20207:00 amRNSShare Price Movement / Exercise of Warrant
22nd Sep 20204:40 pmRNSSecond Price Monitoring Extn
22nd Sep 20204:36 pmRNSPrice Monitoring Extension
14th Sep 20207:00 amRNSExercise of Warrants and Warrant Update
9th Sep 20206:01 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.